人工腎臓市場：デバイスタイプ別、エンドユーザー別、透析別、地域別、2026-2032年

人工腎臓市場の評価、2026-2032年

透析を必要とする患者の増加ウェアラブル人工腎臓や埋め込み型人工腎臓など、腎代替療法の技術進歩も市場のイノベーションを促進しています。人工腎臓のニーズは2024年に664億9,000万米ドルを超え、2032年には6,055億米ドルに達します。

さらに、腎臓移植の利点に対する意識の高まりや、新興国におけるヘルスケアインフラの拡大も市場拡大に寄与しています。これらの要因により、さまざまな産業で人工腎臓の使用が増加しており、2026年から2032年までのCAGRは35.08%で成長する見込みです。

人工腎臓市場定義/概要

人工腎臓は透析器としても知られ、血液中の老廃物や余分な水分をろ過することで体内の電解質バランスを維持し、毒素の蓄積を防ぐなど、天然の腎臓の基本的な機能を果たす医療機器です。主な用途は慢性腎臓病や急性腎不全の治療で、腎移植を受けられない患者に生命維持のための腎代替療法を提供します。将来的には、バイオテクノロジーとナノテクノロジーの進歩により、より効率的で持ち運び可能な人工腎臓の開発が期待され、生体工学的に設計された臓器や、連続透析治療を提供するウェアラブルデバイスなどの技術革新につながる可能性があります。

費用対効果の高い治療に対する需要の高まりが人工腎臓市場を後押し？

慢性腎臓病（CKD）の有病率の増加と費用対効果の高い治療オプションに対する需要の高まりが、人工腎臓市場を大きく後押ししています。米国疾病予防管理センター（CDC）によると、米国では約3,700万人の成人がCKDに罹患しており、さらに数百万人がその危険にさらされています。ヘルスケアの状況がバリューベースケアにシフトするにつれ、医療提供者は、腎移植や長期入院に伴う高額な費用をかけずに効果的な治療を提供できる、手頃な価格のソリューションをますます求めるようになっています。

さらに、腎臓病の経済的負担から、より利用しやすい治療法の必要性が高まっています。米国国立糖尿病・消化器・腎臓病研究所（NIDDK）の報告によると、末期腎不全（ESRD）患者の透析にかかる年間費用は、患者1人当たり9万米ドルを超えることがあり、患者と医療システムの両方に対する経済的負担が大きいことが明らかになっています。その結果、治療費の削減と効率の向上を目指した人工腎臓技術の革新は、患者の予後を改善しつつ、手頃な価格のヘルスケアソリューションに対する需要の高まりに応えるために不可欠なものとなっています。

データセキュリティとプライバシーの懸念は人工腎臓市場の成長を妨げるか？

データセキュリティとプライバシーの懸念は、特に技術の進歩によってデジタルヘルスソリューションが医療機器と統合されるにつれて、人工腎臓市場の成長に重大な課題をもたらします。人工腎臓、特に遠隔医療プラットフォームやモニタリングシステムに接続された人工腎臓は、健康データや治療履歴を含む機密性の高い患者情報を収集・送信します。ヘルスケアにおけるサイバー攻撃やデータ漏洩の頻度が高まっていることから、こうした情報が悪用される可能性に対する警戒感が高まっており、患者や医療提供者がこうした革新的ソリューションの採用を躊躇する要因となっています。

さらに、米国における医療保険の相互運用性と説明責任に関する法律（HIPAA）のようなデータ保護に関する厳しい規制により、メーカーは安全な技術とコンプライアンス対策に多額の投資を行う必要があります。このような複雑さとコストの上乗せは、特に中小企業にとって、人工腎臓の開発と普及を遅らせる可能性があります。ヘルスケアでは患者の信頼が最も重要であるため、強固なデータ保護対策と透明性の高い慣行を通じてこうしたセキュリティ上の懸念に対処することは、人工腎臓技術に対する信頼を醸成し、市場の持続的成長を確保する上で極めて重要です。

目次

第1章 世界の人工腎臓市場の導入

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 世界の人工腎臓市場の展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 人工腎臓の世界市場、デバイスタイプ別

• 概要
• ウェアラブル人工腎臓
• 埋め込み型人工腎臓

第6章 人工腎臓の世界市場：エンドユーザー別

• 概要
• 病院
• 専門クリニック

第7章 人工腎臓の世界市場：透析別

• 概要
• 血液透析
• 腹膜透析

第8章 人工腎臓の世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第9章 世界の人工腎臓市場の競合情勢

• 概要
• 各社の市場ランキング
• 主な発展戦略

第10章 企業プロファイル

• B. Braun Melsungen AG
• Asahi Kasei Medical Co. Ltd.
• DaVita Inc.
• NIPRO Medical Corporation
• Nikkiso Co., Ltd.
• Fresenius Medical Care AG & Co. KGaA
• Baxter
• Merit Medical Systems
• Medtronic
• Xcorporeal, Inc.

第11章 付録

• 関連調査

Artificial Kidney Market Valuation - 2026-2032

The increasing number of patients requiring dialysis. Technological advancements in kidney replacement therapies, such as wearable and implantable artificial kidneys, are also driving innovation in the market. The need for artificial kidney is surpassing USD 66.49 Billion in 2024 and reaching USD 605.5 Billion by 2032.

Additionally, the growing awareness of the benefits of kidney transplantation and the expanding healthcare infrastructure in emerging economies contribute to market expansion. These factors contribute to the increasing use of artificial kidney in a variety of industries is expected to grow at a CAGR of 35.08% about from 2026 to 2032.

Artificial Kidney Market: Definition/ Overview

An artificial kidney, also known as a dialysis machine, is a medical device that performs the essential functions of a natural kidney by filtering waste products and excess fluids from the blood, thereby maintaining the body's electrolyte balance and preventing the accumulation of toxins. Its primary application is in the treatment of individuals with chronic kidney disease or acute kidney injury, providing life-sustaining renal replacement therapy for patients who cannot undergo kidney transplantation. Looking to the future, advancements in biotechnology and nanotechnology hold promise for the development of more efficient and portable artificial kidneys, potentially leading to innovations such as bioengineered organs and wearable devices that offer continuous dialysis treatment, significantly enhancing patients' quality of life and reducing the need for traditional dialysis sessions.

Will Rising Demand for Cost Effective Treatment is Propelling the Artificial Kidney Market?

The increasing prevalence of chronic kidney disease (CKD) and the growing demand for cost-effective treatment options are significantly propelling the artificial kidney market. According to the Centers for Disease Control and Prevention (CDC), approximately 37 million adults in the United States have CKD, and millions more are at risk. As the healthcare landscape shifts towards value-based care, healthcare providers are increasingly seeking affordable solutions that can deliver effective treatment without the high costs associated with kidney transplants or prolonged hospital stays.

Furthermore, the economic burden of kidney diseases necessitates the need for more accessible treatment options. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) reported that the annual cost of dialysis for patients with end-stage renal disease (ESRD) can exceed $90,000 per patient, underscoring the financial strain on both patients and healthcare systems. As a result, innovations in artificial kidney technologies, aimed at reducing treatment costs and enhancing efficiency, are essential to meet the rising demand for affordable healthcare solutions while improving patient outcomes.

Will Data Security and Privacy Concerns Hamper the Growth of the Artificial Kidney Market?

Data security and privacy concerns pose significant challenges to the growth of the artificial kidney market, particularly as advancements in technology integrate digital health solutions with medical devices. Artificial kidneys, especially those connected to telemedicine platforms or monitoring systems, collect and transmit sensitive patient information, including health data and treatment history. The increasing frequency of cyberattacks and data breaches in healthcare raises alarms about the potential misuse of this information, which can deter patients and healthcare providers from adopting these innovative solutions.

Moreover, stringent regulations regarding data protection, such as the Health Insurance Portability and Accountability Act (HIPAA) in the United States, require manufacturers to invest heavily in secure technology and compliance measures. This added layer of complexity and cost can slow down the development and deployment of artificial kidneys, particularly for smaller companies. As patient trust is paramount in healthcare, addressing these security concerns through robust data protection measures and transparent practices will be crucial for fostering confidence in artificial kidney technologies and ensuring sustained market growth.

Category-Wise Acumens

Will Increasing Adoption of Wearable Devices Boost the Artificial Kidney Market?

The rising adoption of wearable devices is expected to significantly boost the artificial kidney market by enhancing patient engagement and facilitating remote monitoring of kidney health. Wearable technologies, such as smartwatches and health trackers, are increasingly being integrated with advanced monitoring systems that can provide real-time data on vital signs, fluid balance, and kidney function. This integration empowers patients to take an active role in managing their health, leading to timely interventions and improved outcomes.

Moreover, the growing trend of telemedicine and remote patient monitoring is driving demand for wearable artificial kidneys, as healthcare providers seek efficient ways to manage chronic conditions without the need for frequent hospital visits.

The implantable artificial kidney segment is the fastest-growing segment, driven by advancements in bioengineering and materials science that aim to create devices capable of mimicking natural kidney functions more effectively.

Will Widespread Availability of Advanced Technologies in Hospitals Fuel the Artificial Kidney Market?

The widespread availability of advanced technologies in hospitals is significantly fueling the artificial kidney market by enhancing the efficiency and effectiveness of renal care. Innovations such as portable dialysis machines, automated systems, and remote monitoring capabilities are making it easier for healthcare providers to deliver high-quality care.

These advancements enable hospitals to offer more comprehensive treatment options, reducing the need for patients to seek alternatives, which in turn drives demand for artificial kidneys. Moreover, the integration of artificial intelligence and data analytics into renal care is improving patient outcomes through personalized treatment plans and real-time monitoring of patient health.

Specialty Clinics is the fastest-growing segment, driven by the increasing trend towards outpatient care and the desire for more personalized treatment options.

Country/Region-wise

Will the Technological Advancement in North America Drive the Expansion of The Artificial Kidney Market?

Technological advancements in North America are poised to significantly drive the expansion of the artificial kidney market. Innovations such as miniaturization of dialysis devices, the integration of artificial intelligence for personalized treatment, and the development of wearable dialysis systems are enhancing the accessibility and efficiency of renal replacement therapies. According to the U.S. Renal Data System, as of 2021, over 786,000 individuals were undergoing dialysis in the United States, and advancements in technology could help meet the growing demand for more effective and convenient treatment options.

Moreover, the increasing investment in research and development, alongside supportive government initiatives, is further propelling market growth. The National Institutes of Health (NIH) reported funding of approximately $690 million in 2022 for kidney disease research, which aims to foster innovations in artificial kidneys and improve patient outcomes. Such financial backing, combined with the rising prevalence of chronic kidney disease-projected to affect about 37 million adults in the U.S. by 2030-underscores the vital role of technological progress in shaping the future of the artificial kidney market.

Will Increasing Number of Well-Equipped Hospitals in Asia Pacific Propel the Artificial Kidney Market?

The increasing number of well-equipped hospitals in the Asia Pacific region is expected to significantly propel the artificial kidney market. As healthcare infrastructure improves, more hospitals are investing in advanced medical technologies, including dialysis machines and artificial kidney devices. According to the World Bank, the number of hospitals in the Asia Pacific region has grown by approximately 20% from 2010 to 2020, reflecting the region's commitment to enhancing healthcare services. This growth not only increases access to treatment for patients with chronic kidney disease but also encourages the adoption of advanced dialysis technologies, thereby expanding the artificial kidney market.

Furthermore, government initiatives aimed at improving healthcare access and the growing prevalence of kidney-related disorders are driving demand for artificial kidneys. The Asia Pacific region accounted for nearly 50% of global end-stage renal disease cases in 2021, as reported by the Global Burden of Disease Study. With an aging population and lifestyle-related health issues on the rise, the need for artificial kidneys is expected to surge. Coupled with the expanding hospital infrastructure, this demand presents a lucrative opportunity for manufacturers and healthcare providers, reinforcing the positive outlook for the artificial kidney market in the region.

Competitive Landscape

The competitive landscape of the artificial kidney market is characterized by a mix of established players and emerging startups, each focusing on innovative features such as real-time tracking, integration with IoT devices, and user-friendly interfaces. Companies are increasingly investing in research and development to enhance product offerings and improve customer service, creating a dynamic and rapidly evolving market environment.

Some of the prominent players operating in the artificial kidney market include:

Braun Melsungen AG, Asahi Kasei Medical Co. Ltd., DaVita Inc., NIPRO Medical Corporation, Nikkiso Co., Ltd., Fresenius Medical Care AG & Co. KGaA, Baxter, Merit Medical Systems, Medtronic, Xcorporeal, Inc.

Latest Developments

In August 2024 Reistone Biopharma reported significant progress in its clinical trials for an innovative artificial kidney that utilizes bioengineered materials to mimic natural kidney function. Preliminary results have shown promising outcomes in terms of biocompatibility and efficacy, paving the way for future regulatory approvals. The company aims to revolutionize renal replacement therapy by providing a more efficient and long-lasting solution for patients with chronic kidney disease.

In July 2024 Dialyze Direct announced the expansion of its home dialysis services, integrating artificial kidney technology into their offerings. This initiative aims to provide patients with greater flexibility and comfort by enabling them to manage their treatment at home. The company is focused on enhancing patient education and support to ensure successful adoption of these advanced technologies in home settings.

In June 2024 Xeltis unveiled groundbreaking results from its research on bioengineered kidneys, which utilize a unique combination of synthetic and biological materials to promote kidney regeneration. The company's innovative approach aims to create a functional artificial kidney that not only replaces lost function but also encourages tissue regeneration.

Artificial Kidney Market, By Category

• Device Type
• Wearable Artificial Kidney
• Implantable Artificial Kidney
• End-user
• Hospitals
• Specialty Clinics
• Dialysis
• Hemodialysis
• Peritoneal Dialysis
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL ARTIFICIAL KIDNEY MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL ARTIFICIAL KIDNEY MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL ARTIFICIAL KIDNEY MARKET, BY DEVICE TYPE

• 5.1 Overview
• 5.2 Wearable Artificial Kidney
• 5.3 Implantable Artificial Kidney

6 GLOBAL ARTIFICIAL KIDNEY MARKET, BY END-USER

• 6.1 Overview
• 6.2 Hospitals
• 6.3 Specialty Clinics

7 GLOBAL ARTIFICIAL KIDNEY MARKET, BY DIALYSIS

• 7.1 Overview
• 7.2 Hemodialysis
• 7.3 Peritoneal Dialysis

8 GLOBAL ARTIFICIAL KIDNEY MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East & Africa

9 GLOBAL ARTIFICIAL KIDNEY MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 B. Braun Melsungen AG
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Asahi Kasei Medical Co. Ltd.
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 DaVita Inc.
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 NIPRO Medical Corporation
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Nikkiso Co., Ltd.
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Fresenius Medical Care AG & Co. KGaA
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Baxter
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Merit Medical Systems
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Medtronic
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 Xcorporeal, Inc.
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments

11 Appendix

• 11.1 Related Research